Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000644530 | SCV000766229 | benign | Hypercholesterolemia, familial, 4 | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001264559 | SCV001442768 | likely benign | not specified | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331196 | SCV002629830 | likely benign | Cardiovascular phenotype | 2018-07-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000644530 | SCV004173995 | likely benign | Hypercholesterolemia, familial, 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711263 | SCV005263457 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ARUP Laboratories, |
RCV000644530 | SCV005879081 | likely benign | Hypercholesterolemia, familial, 4 | 2024-04-29 | criteria provided, single submitter | clinical testing |